PRAGATI 2024 to boost collaborative research on Ayurveda drugs

To inspire collaborative research in the Ayurveda drug industry, the Central Council for Research in Ayurvedic Sciences (CCRAS) launched the platform PRAGATI- 2024 (Pharma Research in AyurGyan And Techno Innovation) on Tuesday. The platform is expected to provide valuable opportunities for research and collaboration and exploit the vast potential of the Ayurveda and herbal industry. 

CCRAS, an autonomous body under the Union Ministry of Ayush, has a huge role in the development of Ayurveda, said Vaidya Rajesh Kotecha, Secretary of the Ministry of Ayush. “The influx of new practitioners and startups presents tremendous growth opportunities and vast potential for industries to expand and advance in the sector,” Kotecha said. 

Prof. Rabinarayan Acharya, Director General of CCRAS, highlighted the growing momentum of Ayush products, particularly Ayurveda, both in India and worldwide. “CCRAS aims to reach each stakeholder.  Students have to understand the importance of research. We have started programs to reach out to teachers and students through research and scholarships,” Prof. Acharya said. 

The quality of Ayush products is fundamentally rooted in rigorous research. There is an urgent need to develop research-based, high-quality, safe and effective Ayurvedic products to convince new users of its long-lasting benefits. “Research and industry must work hand in hand to ensure that their combined efforts ultimately benefit society,” said Dr Koustubha Upadhaya, Advisor (Ayurevda), Ministry of Ayush. 

PRAGATI-2024 presents a unique scope for collaboration between CCRAS and the Ayurveda drug industry. The event was attended by CEOs, MDs, Directors and heads of research units from 37 pharma Companies. The latest newsletter of CCRAS and the CCRAS calendar of activities for 2024-25 was also launched during the event.

Managed by

Leave a Comment: